Neurontin No-Injury Claims Dismissed as Judge Decertifies Class

PHILADELPHIA - A class action alleging claims for off-label promotion of Neurontin has been decertified after the drug's manufacturer was awarded partial summary judgment on breach of express warranty claims and for all other claims brought by plaintiffs who suffered no injury as a result of taking the drug. Clark, et al. v. Pfizer Inc., June Term 2004 No. 1819 (Pa. Comm. Pls., Philadelphia Cty.).

Judge Mark I. Bernstein of the Philadelphia County Court of Common Pleas entered the opinion and order Feb. 9, determining that the alleged fraud perpetrated by Neurontin maker Pfizer Inc. on the medical community does …